Table.
Salivary carriage of SARS-CoV-2∗ in asymptomatic, presymptomatic, symptomatic, and postsymptomatic participants.
| PATIENT METADATA | ASYMPTOMATIC (n = 127) | PRESYMPTOMATIC (n = 18) | SYMPTOMATIC (n = 40) | POSTSYMPTOMATIC (n = 15) |
|---|---|---|---|---|
| Race orEthnicity | ||||
| White | 112 | 15 | 23 | 12 |
| African American | 7 | 0 | 16 | 2 |
| Asian | 3 | 1 | 1 | 0 |
| Hispanic | 5 | 2 | 0 | 1 |
| Age, Y, Mean, Median (Range) | 49.3, 43 (24-71) | 43, 29 (25-69) | 61.1, 64 (25-82) | 42.9, 39.5 (25-65) |
| Sex, No.(Males) | 69 | 7 | 33 | 10 |
| SARS CoV-2 Detection Frequency, No. | 29† | 5‡ | 39§ | 9¶ |
| SARS CoV-2 Copy No. in 1 Milliliter of Saliva, Mean, Median (Range) | 234, 427 (127-912)† | 198, 658 (165-1,210)‡ | 24 × 107, 13 × 105 (10 × 104-96 × 108)§ | 6,491, 5,219 (897-11,256)¶ |
∗
SARS-CoV-2: Severe acute respiratory syndrome coronavirus 2.
†
The groups are statistically different (P < .05, χ2 test for detection frequency and Dunn test for viral copy numbers).
‡
The groups are statistically different (P < .05, χ2 test for detection frequency and Dunn test for viral copy numbers).
§
The groups are statistically different (P < .05, χ2 test for detection frequency and Dunn test for viral copy numbers).
¶
The groups are statistically different (P < .05, χ2 test for detection frequency and Dunn test for viral copy numbers).